Medical/Pharmaceuticals
Japan's Saitama Medical University International Medical Center Joins the TriNetX Network to Study Global Real-World Data on Rare Diseases, Treatments, and Outcomes to Benefit Its Patients
CAMBRIDGE, Mass., March 7, 2023 /PRNewswire/ -- Saitama Medical University International Medical Center, one ofJapan's leading hospitals for the treatment of oncology, cardiology, and stroke cases, has joined the TriNetX Network to utilize global real-world data to better understand rare diseases...
2023-03-07 13:00
2084
Ceva Santé Animale calls to speed up development of critical new vaccines at VIV Asia 2023
LIBOURNE, France, March 7, 2023 /PRNewswire/ -- Ceva Santé Animale, (Ceva), the #5 animal health company present in 110 countries, participates in the VIV Asia inBangkok, Thailand. Earlier today, the One Health company held the "Ceva Innovation Day" pre-opening symposium, featuring a keynote spee...
2023-03-07 12:00
3609
GenScript ProBio Congratulates Eutilex's IND Clearance from MFDS
NANJING, China, March 7, 2023 /PRNewswire/ -- Recently, Eutilex, a partner of GenScript ProBio, announced MFDS(Ministry of Food and Drug Safety) clearance of its hepatocellular carcinoma clinical trial application for innovative CAR-T program (EU307). GenScript ProBio extends congratulations o...
2023-03-07 10:00
2300
Hummingbird Bioscience Exercises Its Option to License the Clinical Trial Results from Cancer Research UK to Support Further Development of HMBD-001
SINGAPORE and LONDON, March 6, 2023 /PRNewswire/ -- Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, and Cancer Research Horizons, the innovation arm of Cancer Research UK (CRUK), today...
2023-03-06 21:00
2184
Confirmatory clinical trial of Liwen RF™ ablation system in China concluded
HANGZHOU, China, March 6, 2023 /PRNewswire/ -- On March 3, Venus Medtech ( Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen RF™ ablation system developed by the Company has successfully enrolled one patient at West China Hospita...
2023-03-06 07:29
2663
Results of CLDN18.2-targeting Immuno-PET Probe for Non-invasive Imaging in Gastrointestinal Tumors Published
SUZHOU, China, March 3, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, today announces that the study ...
2023-03-03 14:56
2834
AffaMed Technologies Announces the First Implantation in the China Registrational Clinical Trial of MINI WELL®, the Progressive Extended Depth-of-Focus IOL
SHANGHAI, March 3, 2023 /PRNewswire/ -- AffaMed Technologies ("AffaMed"), a joint venture established between AffaMed Therapeutics and SIFI S.p.A., today announced the completion of the first patient implantation in the Registrational Clinical Trial of its MINI WELL® progressive Extended Depth-o...
2023-03-03 09:00
3906
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
LONDON and HONG KONG, March 2, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scientific Advisory Board (the 'SAB') to provide strategic input based on their scientific knowledge and c...
2023-03-02 20:00
2884
AIRS Medical Applauded by Frost & Sullivan for Reducing MRI Equipment's Exam Wait Times with Its SwiftMR™ Technology
SwiftMR™ improves image quality of MRI scans, enables easy installation and use, andadapts to healthcare providers' existing scanners because it is a stand-alone offering. SAN ANTONIO, March 2, 2023 /PRNewswire/ -- Recently, Frost & Sullivan researched the artificial intelligence (AI)-powered ma...
2023-03-02 20:00
2398
Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376
SHANG HAI, March 2, 2023 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. ("Abbisko Therapeutics" hereafter) today announced that it has entered into an exclusive Out-License Agreement (the "Agreement" hereafter) with Shanghai Allist Pharmaceuticals Co., Ltd., ("Allist" hereafter) for the further ...
2023-03-02 19:15
3398
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Debiopharm obtains global rights from Novo Nordisk for the development of their
ubiquitin-specific protease 1 (USP1) inhibitor
LAUSANNE, Switzerland, March 2, 2023 /PRNewswire/ -- Debiopharm (
www.debiopharm.com
2023-03-02 09:00
2932
ClinChoice Acquires CROMSOURCE, Expanding its Global Presence
PHILADELPHIA, SHANGHAI and VERONA, Italy, March 2, 2023 /PRNewswire/ -- ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters inVerona, Italy and its US headquarters ...
2023-03-02 04:12
3116
AtomVie Global Radiopharma Inc. builds industry-leading radiopharmaceutical CDMO facility in Hamilton, Ontario
TORONTO, March 1, 2023 /PRNewswire/ -- AtomVie Global Radiopharma Inc. (AtomVie ) is pleased to announce the execution of a Lease Agreement with Panattoni Development Company inHamilton, Ontario, Canada, for its new state-of-the-art facility. AtomVie's new facility will be dedicated for high volum...
2023-03-01 22:00
1543
National Comprehensive Cancer Network Updates Annual Conference with New In-Person Venue, Hybrid Format, Expert-Led Sessions, Highlighted Research Perspectives, and Small-Group Conversations
Annual conference featuring more than a thousand worldwide oncology professionals will present new research findings, latest NCCN Guidelines updates, and best practices achieving quality cancer care delivery, inOrlando March 31—April 2, 2023. PLYMOUTH MEETING, Pa., March 1, 2023 /PRNewswire/ -- ...
2023-03-01 21:33
1721
Cambrex Recognized with CDMO Leadership Awards for 9th Consecutive Year
EAST RUTHERFORD, N.J., March 1, 2023 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized with 2023 CDMO Leadership Awards in the categories of Quality, Service, Expertise, and Compatibility. Additionally...
2023-03-01 19:00
2382
Digital Transformation Across Life Sciences Industry Boosts Instrumentation Market
Automation and robotization to ensure industrywide streamlining and increase future growth potential SAN ANTONIO, March 1, 2023 /PRNewswire/ -- The development of next-generation sequencing (NGS) technology, a wide array of informatics, and robotics are some of the most recent technological adva...
2023-03-01 16:12
2004
A promising picture for multi-cancer early detection in Southeast Asia - latest update from biotech firm Gene Solutions
HO CHI MINH CITY, Vietnam, March 1, 2023 /PRNewswire/ -- In January 2023,
Vietnam's Medical Genetics Institute & Gene Solutions
2023-03-01 09:30
2627
AMPLIFY HEALTH ASIA PTE LIMITED APPOINTS DR AXEL BAUR AS CHIEF EXECUTIVE OFFICER
* Dr Axel Baur succeeds Dr Jonathan Broomberg as Chief Executive Officer in planned succession as Amplify Health Asia Pte Limited accelerates its commercial strategy inAsia Pacific * Dr Broomberg will reassume his role as CEO of Vitality Health International and Global Head of Health Insuranc...
2023-03-01 09:00
2475
Global Cold Chain Transport Track & Trace Revenues in Pharma to Reach US$2.9 billion by 2027
For pharmaceutical companies to ensure product integrity and maintain regulatory compliance, deeper product monitoring, enhanced cold chain infrastructure, and focused automation will be critical NEW YORK, Feb. 28, 2023 /PRNewswire/ -- The global pharmaceutical (pharma) industry will surpassUS$1...
2023-02-28 21:30
1839
JW Therapeutics Announces Initiation of Clinical Study of JWATM214 in Patients with Advanced Hepatocellular Carcinoma
SHANGHAI, Feb. 28, 2023 /PRNewswire/ -- JW Therapeutics (HKEX: 2126), an independent and innovative biotechnology company focusing on developing, manufacturing and commercializing cell immunotherapy products, announced the initiation of clinical study of JWATM214 in patients with advanced hepato...
2023-02-28 17:30
2687
Week's Top Stories
Most Reposted
QDX Co-Founder Giuseppe Barca Awarded Prestigious Gordon Bell Prize, Pioneering Advancements in Drug Discovery Technology
[Picked up by 303 media titles]
2024-11-26 18:49ITAP 2024 sets the stage for a more connected advanced factory ecosystem with focus on AI, advanced robotics and sustainability
[Picked up by 298 media titles]
2024-11-28 17:24Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
[Picked up by 296 media titles]
2024-11-26 13:00Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
[Picked up by 281 media titles]
2024-11-29 20:33
MediSun Energy Raises $8.75M Seed Round with Vynn Capital to Drive MENA Expansion and Advance Osmotic Energy Innovation
[Picked up by 280 media titles]
2024-11-25 10:00
Most Read
Mentech at COP29: Showing the Eco-friendly Lifestyle with Technological Innovation
2024-11-29 20:33
6487
Southeast Asian Consumers Raise Online Security Concerns, New GSMA Survey Shows
2024-11-26 13:00
5157